Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Cash & Equivalents (2017 - 2025)

Cirtran's Cash & Equivalents history spans 14 years, with the latest figure at $9589.0 for Q4 2025.

  • Quarterly results put Cash & Equivalents at $9589.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $9589.0 (changed N/A YoY), and the annual figure for FY2025 was $9589.0, changed.
  • Cash & Equivalents for Q4 2025 was $9589.0 at Cirtran, down from $19274.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $198891.0 in Q1 2023 to a low of $1210.0 in Q1 2025.
  • The 5-year median for Cash & Equivalents is $18081.0 (2022), against an average of $30479.7.
  • The sharpest move saw Cash & Equivalents skyrocketed 420.96% in 2023, then tumbled 98.49% in 2024.
  • Year by year, Cash & Equivalents stood at $5472.0 in 2021, then soared by 230.43% to $18081.0 in 2022, then rose by 29.43% to $23402.0 in 2023, then plummeted by 87.2% to $2996.0 in 2024, then skyrocketed by 220.06% to $9589.0 in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $9589.0, $19274.0, and $4335.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.